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ABSTRACT: During the COVID-19 pandemic, the demand for specific medical equipment such as personal 
protective equipment (PPE) has rapidly exceeded the available supply around the world. Specifically, simple 
medical equipment such as medical gloves, aprons, goggles, surgery masks and medical face shields have 
become highly in demand in the healthcare sector in face of this rapidly developing pandemic. This difficult 
period strengthens the social solidarity by an extent parallel to the escalation of this pandemic. Education and 
government institutions, commercial and non-commercial organisations and individual home makers have 
produced specific medical equipment by means of additive manufacturing (AM) technology which is the 
fastest way to create a product, providing their support for urgent demands within the healthcare services. 
Medical face shields have become a popular item to produce and many design variations and prototypes have 
been forthcoming. Although AM technology can be used to produce several types of non-commercial 
equipment, this rapid manufacturing approach is limited by its longer production time as compared to 
conventional serial/mass production and the high demand. However, most of the individual designer/maker-
based face shields are designed with little appreciation of clinical needs and non-ergonomic. They also lack of 
professional product design and are not designed according to additive manufacturing (DfAM) principles. 
Consequently, production time of up to 4-5 hours for some products of these designs are needed. Therefore, a 
lighter, more ergonomic, single frame medical face shield without extra components to assemble would be 
useful, especially for individual designers/makers and non-commercial producers to increase productivity in a 
shorter timeframe. In this study, a medical face shield which is competitively lighter, relatively more 
ergonomic, easy to use and can be assembled without extra components (such as elastic bands, softening 
materials and clips) was designed. The face shield was produced by AM with relatively shorter production 
time. Subsequently, finite element analysis-based structural design verification was performed and a three-
dimensional (3D) prototype was produced by an OEM 3D printer (Fused Deposition Modelling). This study 
demonstrated that an original face shield design with less than 10 g material usage per single frame was 
produced in under 45 minutes of fabrication time. This research also provides a useful product design for 
additive manufacturing of simple medical equipment such as face shields through advanced engineering 
design, simulation and additive manufacturing applications as an essential approach to battling coronavirus-
like viral pandemics. 
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On 31 December 2019, the World Health Organisation (WHO) Country Office in China was informed 
of cases of pneumonia which had unknown etiology from Wuhan City, Hubei Province of China. Following 
the identification and confirmation of a new type of coronavirus called 2019-nCoV by the Chinese 
authorities [1], WHO officially named the disease caused by the coronavirus as COVID-19, which stands for 
“coronavirus disease 2019” on 11 February 2020 [2], and declare the pandemic on 11 March 2020 [3]. Since the 
date of the first case of this virus spreading, the World has been struggling with this emergent state. During 
this period, international and national authorities have been announcing public advice and putting in place 
legal regulations regarding social behavioural habits and the use of personal protective equipment (PPE) for 
public and healthcare services. During this pandemic, healthcare institutions have become one of the most 
hazardous environments to work in, especially for healthcare workers (HW) who deliver care and services to 
the sick and ailing either directly as medical doctors and nurses or indirectly as aides, helpers, laboratory 
technicians, or even medical waste handlers, who are considered to be in the high-risk groups [4]. The outbreaks 
of serious airborne infectious diseases, such as Severe Acute Respiratory Syndrome (SARS), Avian Influenza 
and now the COVID-19, as well as severe infectious agents associated with body fluid exposures (e.g. Ebola 
virus) have called for increased attention to face/eye protection as the face is the most common body part 
exposed to the acutely-expelled aerosols of patient body fluids during HW-patient interaction [5].  
Although it is understood that wearing a surgical face mask may provide protection during distanced 
interaction in the patients room between the HW and patient who has suspected or confirmed COVID-19, the 
use of additional PPE for closer operations potentially involving acutely-expelled aerosols of body fluids 
would be a necessity. Therefore, many international and national health service authorities/organisations 
advise the use of personal PPE for respiratory, eye/mouth/face, body and hand protection while interacting 
with COVID-19 patients to avoid or minimise any likely contact, droplet and airborne transmission [6-8]. WHO 
also published a guide on the recommended types of PPE to be used in the context of SARS-CoV-2 (the virus 
causing COVID-19), according to the setting, personnel and type of activity [9]. 
For instance, the research carried out with cough aerosol and breathing simulators loaded with influenza 
virus (aerosol volume mean diameter of 8.5 μm) indicated 96% and 92% reductions in the risk of inhalational 
exposure immediately after a cough if a face shield at distances of 46 cm and 183 cm were used, respectively. 
In the case of smaller aerosol diameter of 3.4 μm, the protection of the face shield is 68% at 46 cm immediately 
after the cough and the protection rate decreases to 23% over 1–30 min post-cough (in the case of remaining 
airborne particles) [10]. 
It is understood that, in addition to face shield equipment, the use of surgical masks such as N95, FPP2 
and FFP3 will give a more effective and thorough protection during closer HW-patient interaction. Although 
there are risky cases for airborne transmitted viruses (which could have the ability to remain in the air for 
extended periods), in the case of larger aerosol droplet explosion, face shield (visor) products which have 
simple design and manufacturable features would provide superior protection. 
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This face shield (visor) equipment could be designed and produced for single use (disposable) or 
reusable following disinfection. In fact, before this pandemic, millions of healthcare workers, dental providers, 
veterinary care personnel, laboratory workers, pre-hospital emergency medical providers, police, firefighters, 
and custodial staff dealing with spills and contaminated waste have already been classified as the potential 
users of face shields. In addition to meeting the demand of this pre-existing group of face shield users, the need 
for this type of PPE in many countries, including Turkey and the United Kingdom, has increased drastically 
since the COVID-19 pandemic. On 3 March 2020, WHO expressed the concern over the shortage of PPE that 
could endanger HW worldwide; therefore,  announced a call for increased manufacture of face shield by 40 % 
to meet the rising global demand for this type of PPE [11]. Based on WHO modelling, an estimated 89 million 
medical masks are required for tackling with COVID-19 each month [11]. About 76 million of examination 
gloves are required, and the international demand for goggles (including face shield equipment) now stands at 
1.6 million per month. 
In face of this high demand for PPE (specifically for face shield equipment), visors that are commercially 
produced by conventional manufacturing methods (mostly plastic injection moulding) could be supplied on 
time, and the high demand for this PPE has raised the unit product costs and the shipping rate. Conversely, this 
situation strengthens our social solidarity to address the issues pertaining to this pandemic. Many educational 
and government institutions, commercial and non-commercial organisations and home/individual makers 
produced face shield products (not mass/serial production) and shipped/donated them to personal-public users 
and healthcare sectors. In many cases, additive manufacturing (AM) technology was utilised for their prototype 
designs as it is the fastest way to obtain a usable product/prototype. Use of this manufacturing technology with 
easily accessible relatively professional (trade marks) and OEM 3D printers has become very popular and is 
productive enough to meet the high demand for PPE.  
A face shield (visor) product has simple structural and functional design features which consist of two 
main components: the frame (metal- or plastic material-based) and the transparent protective visor shield 
(mostly plastic material-based). However, additional components such as elastic bands (frame-head holder), 
face contact softening materials (sponge, foam, rubber etc.) and clips for fastening the transparent shield to the 
frame can also be included. 
Various concept designs for face shield products generated by AM for rapid prototyping/manufacturing 
have been introduced in addition to commercially existing ones (Figure 1). However, most of these products 
were not carefully designed with due consideration to professional and ergonomic product design principles 
and design for additive manufacturing (DfAM) approaches. A design can be functional and may correspond 
to the needs within pre-defined design specifications; however, this may not indicate that the design has 
structurally and functionally optimised features. For most of the designs generated, it was not known where or 
how they were approved. These designs also have relatively longer production and component assembly times 
per unit product (more than 4-5 production hours; about 2 hours in average), and some of the products are 
heavier considering their custom designs. Besides, most of them which are equipped with additional 
components such as elastic bands, softening materials, fastening clips, etc. could cause user discomfort after 
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using for long working hours and constant taking on/off  operations. These facts appear as disadvantages for a 
product within the context of ergonomics and total AM -based production time. Additionally, from a post-
prototyping perspective, most of these products do not have convenient structural design features that are 
amenable for commercial mass/serial production using conventional manufacturing methods such as plastic 
injection moulding. Therefore, a lighter, more ergonomic, single frame medical face shield without extra 
components for assembly would be useful for home makers, individual designers/makers and non-commercial 
producers (primary target) in order to provide effective, functional rapid prototyped products, which may have 
a commercial potential (secondary target) in a relatively shorter time. The disadvantages of the current PPE 
manufacturing method were the main sources of motivation for this design study as the product designs are 
dynamic, and can be seen changing stages on an existing product over time, in shape and function. These 
changing stages can be in different range and sudden, others move step by step. In any case, the major aim of 
the change is to improve design, to make the product more effective or, put simply, just more appropriate for 
use in the current pandemic (i.e. low-cost, quick to produce and disposable). 
Considering the aforementioned specific product design issues, the aim of the current study was to 
design a competitively lighter, relatively more ergonomic and easy-to-use original medical face shield which 
can be produced within relatively shorter production times, assembled without extra components (such as 
elastic bands, softening materials, clips etc.), fully amenable to production using AM technology, and directed 
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2. Material and Method 
 
2.1. Background, Design Process, and Original Design Details 
Although international standards for industrial PPE (such as ANSI/ISEA Z87.1-2020, “American 
National Standard for Occupational and Educational Personal Eye and Face Protection” and British Standards 
of BS 7028:1999 BS EN 168:2002, BS EN 166:2002; BS EN 13921:2007, Statutory Instrument 2002 No. 1144 
for eye protection regulations and specifications) are available, it is reported that there is currently no universal 
standard for eye/face protection from biological hazards during medical applications [10,12]. The common point 
related to the product descriptions and functionality From the infection control standpoint, protector 
components serve to minimise or prevent eye and face exposure of the wearer to sprays, splashes, or droplets 
of blood, body fluids, excretions, secretions, and other potentially infectious materials in occupational and 
educational environments where biological hazards are expected. Hence, in this perspective, various face 
shield design samples and patent registrations can be found from a simple internet search; however, the number 
of informative scientific publications for user guides, design details, AM and conventional or non-conventional 
manufacturing applications of face shield are very limited. Within the limited literature, a useful scientific 
review regarding face shields used for infection control in order to assist in the selection and proper utilisation 
of this type of PPE was published by Roberge (2016). Additionally, WHO, NHS England and TMA Turkey 
have been updating their advisory guidelines/publications for the use of medical PPE. These are the sources 
available to collect reference information related to design and structure, regulatory standards, and guidelines 
to proper use and selection of the PPE and describe the product as PPE that provides barrier protection to the 
facial area and related mucous membranes (eyes, nose, lips). Consequently, these sources were carefully 
considered in describing the requirements for the design study detailed in this paper. 
For the term “design”, there is no single universal description in the product development applications; 
however, design is commonly considered as a total iterative process within the scopes of engineering design, 
product design and industrial design applications; this begins with an idea or requirement and ends with a fully 
described product (or process or services). As shown schematically in Figure 2 adapted from two of well-
known references, Budynas and Nisbett (2011) outlines the idealised, iterative, top-down phases in design [13] 
and Kamrani and Nasr (2010) draws an engineering design process path which indicates a similar process for 
the product design [14]. Additionally, the result of the design activity is often expected to be original, adding 
value to the existing designs by solving problems in new ways [15] which is the emphasis in this research on the 
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For the first stage of the design process, essential design function objectives for an original face shield 
product compatible with an AM production approach were defined as follows:  
F1. Original ergonomic design, easy-to-use form with stable holding elasticity and equipped with as 
few components as possible 
F2. Single frame design which is convenient for AM production (DfAM approach) 
F3. Specific product originality feature: comfortable, with non-classic goggle nose pad and no ear 
hook structural features 
F4. No additional components used in the assembly of the frame and the transparent shield (such as 
softening materials, fastening clips etc.) 
F5. As little as possible additional processing time in preparation/assembly of the linkage points 
between the frame and the transparent visor  
F6. Biodegradable thermoplastic polymer / Polylactic Acid (PLA) material-based production (for AM 
process) 
F7. Less than 10 g product weight (no supports during AM production) 
F8. Less than 60 minutes AM production time through OEM machine (at 60 m s-1 layering speed, in-
fill rate of 100%) (production time may well be shorter with industrial AM equipment) 
F9. Minimum eight products per day from one OEM machine during AM production stage (8 working 
hours) 
F10. Through simple design changes/revisions, generated frame design should conveniently have 
potential for conventional manufacturing methods (such as plastic injection moulding) in addition 
to AM-based prototyping 
 
The innovation process, which can provide solutions for design needs, normally starts at the stage of 
conceptual design. A concept solution as the basis for the final design under pre-defined design needs and 
constraints can be generated from a 'stand-off' between two sets of influences: the basic objective is 
to keep to the required size, shape and 'look' (aesthetic) of the design, whilst improving upon cost 
(such as material weight), lifetime and integrity (Figure 3)  [16]. In this regard, five design candidates, 
which have the potential to meet with these pre-defined objectives, were designed and proposed at 
the concept stage. These candidates were analysed through Technical Functional Analysis (TFA) and 
the best candidate design was selected for prototype testing. The core design contours and the concept 






























Figure 3. The concept design candidates 
 
2.2. Technical Functional Analysis 
Redesigning/improving an existing product (different design for same functionality) on the market can 
pose significant challenges even to the most experienced professional. Considering the importance of the 
product application as discussed within this work, the authors based their redesign/design improvement or new 
design decisions on the guidelines given from the Value Analysis (VA) methodology developed by L.D. Miles 
in 1948 [17]. More specifically, TFA was deployed in order to develop the optimal technical solution that best 
meets the concrete expression of the customers’ need, at minimum cost. External and internal functional 
analysis takes into consideration the main functions that the face shield needs to perform in order to meet both 
customer expectations and manufacturer specifications [18]. TFA offers a variety of tools and instruments, but 
for the purpose of this study, the following main stages were deployed: Function identification and 
characterisation; Ranking and valuation of the functions; Economic dimensioning; Result and Critical 
Evaluation of the functions; Proposal of concepts. TFA can be conducted as an iterative method, which allows 
product performance improvement with each new step, thus obtaining at the end of the process an optimised 
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concept. FAST (Function Analysis System Technique) diagrams [19] were used for all lifecycle stages of the 
face shield in order to accurately identify the main functions. Based on FAST and in relation to the main 
ten design objectives identified before for the face shield’s functions were defined.  
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2.2.1. Functions importance levels 
A TFA team comprised of ten medical experts and industry specialists established the importance levels 
of the face shield by objectively grading and ranking each function in relation to the others. The valuation 
matrix is composed by weighting the answers of all ten team members and their final rankings are displayed 
in Table 1. 
 














The final valuation matrix shows that F10 and F4 are the most important functions in value, namely that 
the redesigned face shield should allow an easy transition from AM processes to plastic injection moulding 
and it should have a clean, simple one-part design and avoid fasteners, softening and holding bands. This 
specific TFA stage highlights which of the functions the redesign should focus on, from the value point of 
view. Function value weightings are noted with xFi, where i = 1÷10. Based on the results obtained from the 
valuation matrix, the following percentage values were obtained: xF1 = 8.181 %, xF2 = 6.0 %, xF3 = 12.0 %, xF4 
= 12.545 %, xF5 = 11.091 %, xF6 = 7.091 %, xF7 = 10.909 %, xF8 = 9.455 %, xF9 = 9.455 %, xF10 = 13.273 %. 
 
2.2.2. Economic dimensioning of the functions 
For the second step of TFA, economic dimensioning of the functions was conducted in accordance with 
thorough benchmarking in the medical device sector. Costs were estimated based on Ruffo et al (2006) and 
Hopkinson and Dicken’s (2003) models [20,21], in which they propose that the total cost (C) is the sum of the 
cost of the raw materials and the indirect costs, as shown in equation (1). The indirect cost of hourly activities 
is shown in Table 2. 
 
FUNCTIONS F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 TOTAL
F1 1 0.3 0.8 0.9 0.6 0.3 0.7 0.6 0.5 0.8 6.5
F2 0.7 1 0.7 0.9 0.8 0.5 0.5 0.9 0.9 0.8 7.7
F3 0.2 0.3 1 0.6 0.5 0.3 0.5 0.2 0.3 0.5 4.4
F4 0.1 0.1 0.4 1 0.3 0.4 0.6 0.4 0.3 0.5 4.1
F5 0.4 0.2 0.5 0.7 1 0.4 0.5 0.3 0.3 0.6 4.9
F6 0.7 0.5 0.7 0.6 0.6 1 0.6 0.8 0.8 0.8 7.1
F7 0.3 0.5 0.5 0.4 0.5 0.4 1 0.4 0.5 0.5 5
F8 0.4 0.1 0.8 0.6 0.7 0.2 0.6 1 0.5 0.9 5.8
F9 0.5 0.1 0.7 0.7 0.7 0.2 0.5 0.5 1 0.9 5.8




10.91% 9.46% 9.46% 13.27% 100%8.18% 6.00% 12.00% 12.55% 11.09% 7.09%
0.07091 0.10909 0.09455 0.09455 0.13273 1
6 5.2 5.2 7.3 55
0.08181 0.06 0.12 0.12545 0.11091
4.5 3.3 6.6 6.9 6.1 3.9
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𝐶 = 𝑃𝑚𝑎𝑡 ∙ 𝑀 + 𝑃𝑖𝑛𝑑 ∙ 𝑇     (1) 
 
where  Pmat is the price of the raw material, measured in monetary units per kilogram;  
M is the mass of the 3D printed product, measured in kilograms; 
Pind cost rate, measured in monetary units/ hours; 
T is the total production time of one part, measured in hours. 
 





TFA is usually applied to existing products in order to increase their value or lower their costs, through 
redesign strategies. In the case of the face shield, economic dimensioning was based on the hypothesis of 
evaluating the average values of the main characteristics, which can include product weight, product 
performance, direct and indirect costs, manufacturing time, etc. After TFA is deployed, these average values 
are stated as final requirements and metrics with ideal values. Thus, market research considered different types 
of materials and their individual characteristics, costs, life span, recycling procedures, production volumes and 
other particular features of the face shield and of the production process. The research team selected Material 
Extrusion (MEx, also referred to as Fused Deposition Modelling or Fused Filament Fabrication) as the primary 
AM process to produce the redesigned face shield. PLA material was selected due to ease of printing and an 
advantageous cost-performance ratio. Considering that single-part weighs an average of 20 g (weight of 
reference products) and it can be manufactured in 60 minutes from medium grade PLA filament with a price 
of 170 monetary units per kilogram, the total cost of manufacturing one face shield structure is 32.48 monetary 
units. Based on the findings of the market analysis, the total calculated costs were assigned by a TFA specialist 
as presented in Table 3. Each function participates in the total cost with a percentage value, noted with yFi, i = 
1÷10. For the redesign of a face shield, the percentage values of the functions participation in the total costs 
are: yF1 = 9.852 %, yF2 = 6.958 %, yF3 = 13.793 %, yF4 = 15.763 %, yF5 = 10.160 %, yF6 = 5.849 %, yF7 = 7.758 
%, yF8 = 9.236 %, yF9 = 8.312 %, yF10 = 12.315 %. 
 







Activity Cost / hour (monetary units)
Production work / time machine 7.99
Machine costs 14.78
Fixed and variable costs 5.9
Administrative costs 0.41
No. Main Constructing Features F1 F2 F3 F4 F5 F6 F7 F8 F9 F10
Feature 
Cost*
1 Main Body Frame 1 1 - 1.92 1.1 0.53 0.72 1 0.75 1.2 9.22
2 Coronal Plane Positioning System 1 0.56 1.74 1 - 0.46 0.4 0.54 0.3 0.8 6.8
3 Shield Orientation and Fixing System 0.2 - - 0.6 1.6 - 0.2 - 0.2 0.5 3.3
4 Lateral Gripping Features 0.5 0.2 1.74 - 0.3 0.41 0.4 0.46 0.7 0.5 -
5 Forehead Stabilising Rest 0.5 0.5 1 1.6 0.3 0.5 0.8 1 0.75 1 7.95
3.2 2.26 4.48 5.12 3.3 1.9 2.52 3 2.7 4 32.48
0.09852 0.06958 0.13793 0.15763 0.1016 0.05849 0.07758 0.09236 0.08312 0.12315 1
9.852 6.958 13.793 15.763 10.16 5.849 7.758 9.236 8.312 12.315 100
Total Cost
Ratio
Cost of Functions (%)
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Economic dimensioning addresses the comparison between the functions value and cost weightings, 
aimed at the identification of three main function status: a function is too expensive in relation to other 
functions; a function is too expensive compared to its contribution in the products’ value; a function is too 
expensive in relation to the existing manufacturing technical possibilities.  To accurately analyse the relation 
between functions costs and value, four diagrams are plotted (Figure 4). 
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2.2.3. Diagrams 
At this stage, the smallest squares method is used to plot the diagrams necessary for TFA. In order to 
properly deploy the smallest squares method, the following parameters need to be calculated:  
• The regression line: 
𝑦 = 𝑎 ∙ 𝑥                                                             (2) 
where  xi represents the functions value weighting; 




2  represents regression parameter. 
• The estimator S is determined with the smallest squares method: 
𝑆 = ∑(𝑦𝑖 − 𝑎 ∙ 𝑥𝑖)
2 → 𝑚𝑖𝑛                                         (3) 
• The dispersion S’ must be as close as possible to zero value in order to validate the solution.  
𝑆′ = ∑(2 ∙ 𝑎 ∙ 𝑥𝑖
2 − 2 ∙ 𝑥𝑖𝑦𝑖)                                       (4) 
• The angle 𝛼 of the regression line: 
𝛼 = 𝑎𝑟𝑐𝑡𝑔 (𝑎)
180
𝜋
                                                         (5) 
 
All computational elements used in the smallest squares method are presented in Table 4.  
 








After processing the information in Table 4, the following values were obtained: a = 1.0021, α = 





F1 F2 F3 F4 F5 F6 F7 F8 F9 F10
1 xi 8.181 6 12 12.545 11.091 7.091 10.909 9.455 9.455 13.273 100
2 yi 9.852 6.958 13.793 15.763 10.16 5.849 7.758 9.236 8.312 12.315 99.996
3 xi
2 66.929 36 144 157.377 123.01 50.282 119.006 89.397 89.397 176.173 1051.57
4 xi * yi 80.599 41.748 165.516 197.747 112.685 41.475 84.632 87.326 78.59 163.457 1053.78
6 S 2.735 0.894 3.125 10.187 0.911 1.58 10.073 0.057 1.352 0.972 31.886



























Figure 4. The relation between functions cost and value 
 
In Figure 4, Diagram A shows the functions t for the redesign process of a face shield. The diagram was 
constructed using the rankings of the functions by their value, as obtained in the valuation matrix. Diagram B 
represents the ranking of the functions by their functional cost, as defined in the cost distribution matrix. Both 
diagrams are used by the TFA team to compare the functions costs in relation to their contribution to the value 
of the product. It is important for the redesign process to identify the most expensive functions and those with 
the highest weighting in the total cost of the product. This way, secondary functions that are very expensive in 
relation to the objective functions, or even more expensive than these, can be identified for further 
improvement. The weighting of effort for a certain function must match its weighting in the total value of the 
product. Further, to validate these assumptions, regression analysis was used, and the regression line was 
plotted for further analysis.  
The real situation is represented in Diagram C by plotting the regression line y = 1.0021*x, with a slope 
angle of α = 45.05998. The smallest squares method presumes that the estimator S should tend to a minimum 
value and the S’ dispersion in zero. In order to diminish the S value, the points represented by the function 
weightings, must be aligned as perfectly as possible along the regression line. The objective of TFA is to 
redesign and diminish costs or increase the value for the functions corresponding to the points above the 
regression line. By changing those specific points and re-plotting the diagram, the slope of the regression line 
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modifies, and a new situation of TFA can be evaluated. As stated before, the process is iterative, and it is 
undertaken until the requirements of both customer and manufacturer are met.  
The critical evaluation of the functions presented in Diagram D presents the most expensive functions 
in relation to their value. Functions F4, F1 and F2 have disproportionate costs in relation to their value 
contribution. Function F4 was also identified in the first TFA stage as being the second most important in 
value, and thus, the designers will focus on the face shield features that address this specific function.   
Based on the above diagrams, the TFA team concluded that functions F1, F2, F3 and F4 need either a 
lower cost or an increase in value. This implies redesigning and providing new constructive solutions for 
ensuring the structure and the ergonomics of the frame. The redesign process will target ergonomics, single 
frame, and AM compatible face concepts. TFA was further used to define the final product requirements which 
must be followed while designing the face shield. A specification is constructed from a metric and a value [18], 
which correspond to a specific function of the product. A function can have one or more metrics and values. 
The final list of specification objectives in relation to the TFA results is given in Table 5. 
 
















The analysis of alternative designs was undertaken using TFA instruments, in order to select the best 
candidate for further investigation. The selection criteria and their weights were set by the TFA team. As Table 




Functions Requirements Metric Units Limit Values Ideal Values
Elasticity Tensile Strength at Yield MPa > 35.9 34
Ease of usage Ergonomic design Yes/ No Yes Yes
F2 Respect DfAM principles AM technologies - MEX, SLA, SLS MEX
Comfortable Wear period hours > 6 8




Yes/ No Yes Yes
Single frame design Number of components No. 3 2
Allow reuse Sterilisation procedure -









Biodegradable filaments Thermoplastics - PLA PLA
Environmental friendly Recyclable Yes/ No Yes Yes
F7 Light weight Total weight g < 20 10
F8 AM produced
Total production time              
(3D printing  + post 
processing + assembly)
minutes < 60 45
F9 AM produced Production rate products/ day/ machine < 10 8
F10 AM / plastic injection
Modular/ parametric 
design
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Once the first functional prototype of a detail design is exhibited, prototype testing can be performed in 
order to validate the proposed design solution. If the design solution cannot meet the required design 
objectives, the product design process is repeated until a satisfactory desired solution is reached. At this stage, 
it is possible to undertake both virtual prototype and physical prototype-based design verifications. 
 
2.3.1. Virtual prototyping: FEA Verification 
After approval of the design details of Candidate 5, a 3D parametric solid model was constructed in the 
virtual environment and then virtual prototype testing for the product’s elastic deformation ability was realised. 
The findings from the tests were evaluated in the virtual environment for potential design changes. In this 
study, the virtual prototype was tested in order to determine head holding force and deformation behaviour. In 
order to evaluate deformation behaviour of the prototype, finite element method-based structural deformation 
analysis (FEA) was carried out. Structural module of the Ansys Workbench finite element method (FEM)-
based commercial code was employed for the FEA. In the FEA scenarios, head wearing and head holding 
position were simulated. The FEA was set up using assumptions of a linear static loading and homogeneous, 
linear isotropic material model. At the meshing operation, a curvature meshing strategy was utilised and 
skewness metric, which is one of the primary mesh quality measures in a FEA, was checked. The shape and 
asymmetry of distribution can be measured by its skewness, that can be considered as the mesh quality 
verification of a FEM [22]. The skewness value of zero (0) indicates an equilateral cell (best) and a value of one 
(1) indicates a completely degenerate cell (worst) [23]. At the final meshing operation, FEM were created with 
minimum element size of 0.4 mm and the average skewness value of 0.227 was obtained. This value indicated 
that the FE model used in the loading scenarios has an excellent mesh quality. Details related to the FEA set 
















1 Cost 15% 2 0.3 3 0.45 3 0.45 5 0.75 5 0.75
2 Functional characteristics20% 2 0.4 3 0.6 5 1 5 1 5 1
3 Life span 10% 4 0.4 4 0.4 4 0.4 4 0.4 4 0.4
4 Re-usage 5% 4 0.2 4 0.2 4 0.2 3 0.15 3 0.15
5 Complexity 10% 2 0.2 3 0.3 4 0.4 4 0.4 4 0.4
6 DfAM characteristics 20% 2 0.4 3 0.6 3 0.6 3 0.6 4 0.8
7 Ergonomics 5% 3 0.15 4 0.2 4 0.2 4 0.2 4 0.2
8 Environmental effect 5% 4 0.2 4 0.2 4 0.2 4 0.2 4 0.2
Selected Model - - -
*Grading scale: 1 - least important; 5 - most important
- √
Rank 2 3 4 5 1
Candidate 5




Candidate 1 Candidate 2 Candidate 3 Candidate 4
No.
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The results of the FEA scenarios revealed that there was no plastic deformation (permanent deformation) 
during the maximum opening condition of wearing on the head and at the head holding positions. Maximum 
equivalent (Von-Mises) stress during maximum opening condition and at the head holding position were 
96.498 MPa and 58.929 MPa respectively, which are lower than the material tensile stress at yield (which is 
110 MPa). These numerical and visual results obtained from the simulation indicated that the stress distribution 
on the product is uniform and the elastic deformation ability of the product is satisfactorily within the design 
limits. For the second scenario, head holding force after wearing was calculated as 2.744 N against each 
side displacements. This finding was also interpreted as the head holding capability of the product 
and was in a satisfactory comfort range. 
  
























Figure 5. FEA verification virtual prototype 
 
2.3.2. Physical Prototyping 
As a dimensionally accurate physical part, the AM prototype is able to give the designer a sense of the 
appropriateness of form and fit prior to continuing with production [24]. The fastest technique to produce a 
physical prototype, most especially for a complex geometric structure, is utilising AM technology. In short, 
models were created by adding successive layers of material together. In order to evaluate the physical 
prototype of the face shield, an AM approach was utilised in this study; however, the critical point here is that 
DfAM is a challenge for most designers as the convenient design methods that consider the unique capabilities 
of AM technologies are needed. Depending on the capabilities of the AM technology being utilised, DfAM 
can be described as a type of design method whereby functional performance and /or other key product 
lifecycle considerations such as manufacturability, reliability and cost can be optimised [25]. In this regard, a 
useful worksheet / application guide designed for novices to AM was published by Booth et al (2017) [26]. In 
using the DfAM method, some important approaches are in macroscale, mesoscale or microscale design 
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studies: Structural optimisation approach (i.e. size, shape and topological) and manufacturability related to 
AM technology type, AM machine, material, build orientation, surface quality needs, production time, etc.  
The production of the prototype was realised using an OEM - FDM (Fused Deposition Modelling) 
machine with production volume capacity of 200 mm × 220 mm × 220 mm, nozzle diameter of 0.4 mm at 
210℃ nozzle temperature. The production material was PLA (Polylactic Acid) thermoplastic with filament 
diameter of 1.75 mm. Solid modelling and AM setup procedures for the face shield product handled in this 
study were conducted under consideration of these key approaches related to the DfAM methodology. In order 
to obtain time efficiency (short production), optimally designed (geometry and topology) and a functionally 
ready-to-use prototype with satisfying surface quality, production trials were made on STL conversion quality 
(geometrical parameters) and production layer heights during AM operations. The trials showed that despite 
the rearrangments, more precise (use of smaller triangles) STL conversion parameters and shorter production 
layer heights gave a smoother surface quality, the fine level of STL conversion (deviation tolerance: 0.099 mm, 
angle tolerance: 10°, number of triangles: 16736) and the layer height of 0.25 provided satisfactory results in 
use of the physical prototype when considering the time efficiency approach (approximately 35 min. 





















Figure 6. Fabrication of prototype product for physical evaluation 
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2.3.3. Physical prototype trials 
The model of Candidate 5 was highlighted through the TFA and the prototyping stage was successfully 
realised. Additionally, in order to obtain first-hand user opinions about the prototype of Candidate 5, a survey 
was conducted. The survey was completed by health service workers (medical doctors, nurses and the other 
health service workers) at Antalya Training and Research Hospital, Antalya, Turkey) in April 2020. Ten 
questions related to the face shield product evaluation were answered by 15 HWs who used the product in 
routine daily hospital activities. The survey results were interpreted as having a high satisfaction level since 
the answers given to question no. 9 related to satisfaction of using this product was very positive overall, in 
addition to the positive responses to the other questions (40% of those completing the survey found the product 
to be “excellent”, 40% found the product to be “good”, 17% found the product “average”, 7% found the product 
to be “poor” and no-one found the product “insufficient”). Thus, for the final evaluation, it was decided that 
Candidate 5 as the final product design should be approved and the design evaluation undertaken in this 
research was finalised. The participation details, survey questions, variation of the answers given to these 

















































Figure 7. Product evaluation survey and user trials  
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3. Results and Discussions 
After initial sketching and concept evaluation, TFA results suggested an optimum design: Candidate 5. 
Structural design verification was approved in the virtual environment and a physical prototype was tested by 
the experts and a product satisfaction survey was completed by HWs during real, in-situ hospital activities. 
The product satisfaction survey revealed positive responses related to the product design features and usability 
(Figure 7). The frame design was rated with 67% ‘excellent’, 20% ‘good’, and 13% ‘average’ satisfaction. No 
user indicated an insufficiency rate for any of the survey questions. Under these considerations, the product 
design work detailed in this paper was completed and the detailed design for Candidate 5 was approved 
(Figure 8). The single frame design used <10 g FDM filament and took approximately 35 min to build. AM 
production time and only two-hole stamping operations is required to assemble the transparent shield to the 
frame. These product features can be interpreted as the originality and advantages achieved for this product 
against competitors as detailed in the myriad of social media. 
During the product design process, advanced computer aided design, engineering and DfAM methods 
were successfully applied. The objectives given in the design process section were achieved. Critically, light 
weight and relatively shorter AM production times were accomplished. When considering the existing 
products being showcased in social media, the biggest disadvantages were perceived to be relatively longer 
AM production times per unit. Many approaches and concepts for face shield products produced using AM 
technologies have been proposed during the COVID-19 pandemic to support the health services. Although all 
of them provide some level of functionality, many of their design features lack adherence to professional design 
principles, optimum structural topology, ergonomics and the application of DfAM approaches. A common 
goal in an industrial product is to improve product quality, shorten the product development cycle and reduce 
product cost/time. As such, the product detailed in this study has satisfactorily met these conditions. 
Realistically, industry nowadays will not survive in a globally competitive marketplace unless they introduce 
new products of better quality, at lower cost, and with shorter lead times [27].  
AM brings unique considerations for engineers in the design process for medical PPE. An important 
issue in the use of PPE for medical purposes is the biological consideration (including cleaning, sterilisation, 
and biocompatibility). In consideration of unregulated PPE production during this COVID-19 pandemic, 
recently, a discussion was reported by MIT news on the limitations and dangers of using AM/3D printing for 
PPE fabrication [28]. The text reports that one of the biggest risks with AM-fabricated products for COVID-19 
is the false sense of hope as quickly produced PPE inevitably fails to meet any of the needs previously 
discussed. This is crucial when considering critical PPE products such as filtration masks which may need 
expert design consideration and medical/health service authority approvals may do more harm than good. 
Additional risk from unregulated PPE also exists as many FDM filaments retain ambient moisture, which could 
pose a paradoxically increased risk for virus transmission during use or reuse [29]. Similar risks and concerns 
were also reviewed and reported by Clifton et al. (2020) [30]. The authors reported that during this pandemic, 
the open distribution and propagation of PPE prototypes happened before validation and hypothesis 
formulation (in the context of both engineering and biological considerations) that emphasised on the 
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fundamentally important factors for prototype testing, such as number needed to treat and reduce harm for 
patients, and the approval of health service authorities had not been considered. Hence, it was possible to 
highlight the need for universal standardisation for PPE such as medical face shield products. True innovation 
can prevail over brief notoriety and avoid unintentional harm from good intentions led by poor science [30].This 
study provided an original design which was developed based on scientific principles of advanced engineering 
design and AM methods, with the product being convenient for single use (means of economic base) and 
sterilisation (with limited cycles) in case of reuse in a risk-based environment such as COVID-19 (+) with 





























































Figure 8. Technical drawing of Candidate 5.  
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4. Conclusion 
In this study, a competitively lighter, relatively more ergonomic, easy-to-use medical face shield design 
which can be assembled without extra components (such as elastic bands, softening materials and clips) and 
has a relatively shorter AM based production time was successfully realised. The motivation for this study was 
to provide an original AM compatible PPE product (primary target), which was designed in accordance with 
professional product design principles to support social solidarity against COVID-19 pandemic and potential 
future needs. The product design feature is also compatible with plastic injection moulding-based serial 
production (secondary target). The survey carried out in a health service environment revealed that the product 
can be used for medical purposes with a good level of user/HW satisfaction. Taken together, this design study 
satisfactorily responded to the design requirements for a face shield PPE. Although the product provides safety 
features (dimensional features) described by WHO, health safety risks should be carefully considered while 
using this product in health service facilities and public areas. This research provides a useful product design 
case study for informing further research on design, prototyping and manufacture of simple medical equipment 
such as face shields for battling coronavirus-like viral pandemics by employing advanced engineering design, 
simulation and AM applications. 
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